IMMUNOLOGY, CANCER and GLYCOMEDICINE

The mission of our group is to work at the interface of immunology, tumor biology and glycobiology, using a multidisciplinary approach that combines unique cellular and animal prototypes of disease further validated in human patients. We are particularly devoted to understand how glycans can mediate key cellular and molecular processes with impact in immune tolerance, autoimmunity and cancer. The group has a multidisciplinary background being composed of highly motivated biochemists, biologists, clinical investigators that in straight collaboration with centre hospitals share the common long term goal of performing translational research as well as preclinical and clinical validation of rational biomarkers and therapeutic strategies in inflammation, autoimmunity and cancer.